1. Inicio
  2. Proyectos y Estudios
  3. STUDY OF THE EFFECTIVENESS AND SAFETY OF CABOZANTINIB TREATMENT IN PATIENTS WITH ADVANCED RENAL CELL CARCINOMA (RCC) UNDER A SPANISH MANAGED ACCESS PROGRAM AND REAL-WORLD PRACTICE.

STUDY OF THE EFFECTIVENESS AND SAFETY OF CABOZANTINIB TREATMENT IN PATIENTS WITH ADVANCED RENAL CELL CARCINOMA (RCC) UNDER A SPANISH MANAGED ACCESS PROGRAM AND REAL-WORLD PRACTICE.

Datos básicos

ESTUDIO OBSERVACIONAL SOG-CAB-2019-02 HOSPITAL UNIVERSITARI I POLITÈCNIC LA FE Año de incio: 2019 Año de finalización: 2022

Documentos

  • No hay documentos

Participantes

Financiadores - Promotores

GRUPO ESPAÑOL DE TUMORES GENITOURINARIOS (SOGUG)

Compartir